References
- World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia Report of a WHO/IDF Consultation. WHO; 2006. https://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabe-tes_new.pdf Accessed May 5, 2019.
- International Diabetes Federation. Diabetes Atlas. 7th edn. International Diabetes Federation; 2015. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html Accessed May 5, 2019.
- Ma R, Chan J. Metabolic complications of obesity. In: Williams G, Fruhbeck G, eds. Obesity: Science to Practice. United Kingdom: John Wiley & Sons Ltd; 2009:235-270.
- Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. J Am Med Assoc. 1979;241:2035-2038.10.1001/jama.1979.03290450033020
- Mbanya JC, Kengne AP, Assah F. Diabetes care in Africa. Lancet. 2006;368:1628-1629.10.1016/S0140-6736(06)69673-617098063
- Kocur I, Resnikoff S. Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol. 2002;86:716-722.1208473510.1136/bjo.86.7.716
- Boulton AJM. The diabetic foot: a global view. Diabetes Metab Res Rev. 2000;16:S2-S5.10.1002/1520-7560(200009/10)16:1+<;::AID-DMRR105>3.0.CO;2-N11054879
- Oyibo SO, Jude EB, Tarawneh I, et al. The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med. 2001; 18:133-138.10.1046/j.1464-5491.2001.00422.x11251677
- Ma RC, Kong AP, Chan N, Tong PC, Chan JC. Drug-induced endocrine and metabolic disorders. Drug Saf. 2007;30:215-245.1734343010.2165/00002018-200730030-00005
- Expert Committee Report on the Diagnosis of Diabetes. The role of glycated haemoglobin (A1C) assay in the diagnosis of diabetes in non-pregnant persons. Diabetes Care. 2009;32:1327-1334.
- Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of diabetes mellitus. Ann Intern Med. 2002;137:263-272.10.7326/0003-4819-137-4-200208200-00011
- Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-591.1825639310.1056/NEJMoa0706245
- Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.1853991610.1056/NEJMoa0802987
- Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.1255654110.1056/NEJMoa021778
- Yousefzadeh G, Shokoohi M, Najafipour H. Inadequate control of diabetes and metabolic indices among diabetic patients: a population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS). Int J Health Policy Manage. 2014;4:271-277.10.15171/ijhpm.2015.06
- Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589.10.1056/NEJMoa080647018784090
- Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes mellitus. J Diabetes Metab Disord. 2013;12:14.10.1186/2251-6581-12-1423497559
- Garay-Sevilla ME, Malacara JM, Gutierrez-Roa A, Gonzalez E. Denial of disease in type 2 diabetes mellitus: its influence on metabolic control and associated factors. Diabet Med. 1999;16:238-244.1022757010.1046/j.1464-5491.1999.00033.x
- Watanabe M, Yamaoka K, Yokotsuka M, Tango T. Randomized controlled trial of a new dietary education program to prevent type 2 diabetes in a high-risk group of Japanese male workers. Diabetes Care. 2003;26:3209-3214.10.2337/diacare.26.12.3209
- Adachi M, Yamaoka K, Watanabe M, et al. Effects of lifestyle education program for type 2 diabetes patients in clinics: a cluster randomized controlled trial. BMC Public Health. 2013;13:467.2367273310.1186/1471-2458-13-467
- Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker Insights. 2016;11:95-104.27398023
- Glasgow RE, Hiss RG, Anderson RM, et al. Report of the health care delivery work group: behavioral research related to the establishment of a chronic disease model for diabetes care. Diabetes Care. 2001;24:124-130.1119421710.2337/diacare.24.1.124
- Naqvi S, Naveed S, Ali Z, et al. Correlation between glycated hemoglobin and triglyceride level in type 2 diabetes mellitus. Cureus. 2017;9:e1347.28713663
- Campbell NR, Gilbert RE, Leiter LA, et al. Hypertension in people with type 2 diabetes: update on pharmacologic management. Canadian Family Physician Medecin de famille canadien. 2011;57:997-1002, e347-353.21918140
- VinodMahato R, Gyawali P, Raut PP, et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: glycated haemoglobin as a dual biomarker. Biomed Res. 2011;22:375-380.
- Alam AY, Qureshi AA, Adil MM, Ali H. Comparative study of knowledge, attitude and practices among antenatal care facilities utilizing and non-utilizing women. J Pak Med Assoc. 2005;55:53-56.15813628